Nandrolone Decanoate

COMPOSITION:

Each ml contains: Nandrolone Decanoate USP 100 mg
PHARMACOLOGICAL CLASSIFICATION:
Anabolic Steroids

PHARMACOLOGICAL ACTION:

PS LABS 100 is an injectable anabolic preparaon. Aer injecon, Nandrolone Decanoate is gradually
released from the intramuscular depot and subsequently hydrolyzed into nandrolone.
INDICATIONS:
As an anabolic steroid. Certain cases of disseminated breast cancer in women. Osteoporosis due to
androgen deficiency in hypogonadal males.

CONTRA-INDICATIONS:

Not intended for use in children. Known or suspected prostac carcinoma and mammary carcinoma in
the male. Not intended for use in female paents other than those with disseminated breast cancer.
Contraindicated in nephrosis or the nephroc phase of nephris, cardiac and renal failure, hypercalcaemia,
oedema, jaundice, liver disease with impaired bilirubin excreon, tescular and hepac carcinoma.

DOSAGE AND DIRECTIONS FOR USE:

PS LABS 100 should be administered by deep intramuscular injecon.
SIDE-EFFECTS AND SPECIAL PRECAUTIONS:
Virilizaon which appears in sensive women as hoarseness, acne, hirsusm, and increased libido; in
prepubertal boys as an increased frequency of erecons and phallic enlargement, and in girls as an
increase of pubic hair and clitoral hypertrophy. Hoarseness may be the first symptom of vocal change
which may end in a long-lasng, somemes irreversible deepening of the voice.

OTHER ADVERSE REACTIONS MAY INCLUDE:

-Oligospermia and decreased ejaculatory volume; -Suppression of ovarian acvity, atrophy of the breasts
and endometrial ssue. -Amenorrhoea and inhibion of spermatogenesis. -Water and salt retenon. –
Premature epiphyseal closure. -If signs of virilizaon develop, treatment should be disconnued. -Increase
in nitrogen retenon and skeletal weight; -Oedema; -Increased vascularity of the skin; -Increased growth
of the bone; -Elderly males may become over-smulated

PATIENTS WITH THE FOLLOWING CONDITIONS SHOULD BE MONITORED:

Latent or overt cardiac failure, renal dysfuncon, hypertension, epilepsy or migraine (or a history of these
condions), since anabolic steroids may induce salt and fluid retenon; diabetes, since anabolic steroids
may improve the glucose tolerance and decrease the need for insulin or other andiabec drugs;
incomplete statural growth, since anabolic steroids in high dosages may accelerate epiphyseal closure;

skeletal metastases, since anabolic steroids may induce hypercalcaemia and hypercalciuria in these
paents.

INTERACTIONS:

Liver-enzyme-inducing agents may reduce the effects of PS LABS by enhancing its metabolism in the
liver.

KNOWN SYMPTOMS OF OVERDOSAGE AND PARTICULARS OF ITS TREATMENT:

See "Side-effects and special precauons". Treatment is symptomac and supporve.
STORAGE INSTRUCTIONS:
Store at room temperature below 30 °C. Protect from light.